Rights and permissions
About this article
Cite this article
Infliximab cost-effectiveness study methods debated. Pharmacoecon. Outcomes News 445, 5 (2004). https://doi.org/10.2165/00151234-200404450-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404450-00006